ELF4 and neoplasm: Just as others have shown that the expression of various genes, including kinases such as the phosphoinositide 3-kinase and transcription factors such as p53, can have clinical implications [34–38], we show here that patients with low-ELF4 tumours tend to have significantly better clinical outcomes than patients with high-ELF4 tumours.